HiberGene Diagnostics

HiberGene Diagnostics

HiberGene Diagnostics

HiberGene develops, manufactures and markets molecular diagnostic tests for the direct detection of human infectious diseases, using LAMP technology.
Founded
2009
Raised
$8.1M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
£5,200,000
Venture capital (Series B) - 2017
€1,500,000
Venture capital (Series B) - 2016
Team Size
2
Employees
Location
Headquarters
£5,200,000 Venture capital (Series B)
syndicateroom , Crowdfund Insider

Current investment opportunities | Angel-led investments

€1,500,000 Venture capital (Series B)
businesswire

HiberGene Closes First Tranche of Series B Financing